Search:
You do not have permission to access this chart.
Please Sign Up or Login
News for ASLAN Pharmaceuticals Limited (ASLN)
minutes ago | Banggood.com
58 minutes ago | Aliexpress.com
a week ago | GlobeNewsWire
a month ago | Benzinga
a month ago | GlobeNewsWire
a month ago | The Motley Fool
3 months ago | GlobeNewsWire
3 months ago | GlobeNewsWire
3 months ago | GlobeNewsWire
5 months ago | Zacks Investment Research
5 months ago | GlobeNewsWire
5 months ago | GlobeNewsWire
ASLAN Pharmaceuticals Limited, a clinical-stage immunology and oncology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company’s clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and a small molecule inhibitor targeting oncology. Its partners include Almirall, Array BioPharma, Bristol-Myers Squibb, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.
Sector:
HealthcareIndustry:
BiotechnologyAddress:
ASLAN Pharmaceuticals Limited 83 Clemenceau Avenue No. 12-03 UE Square Singapore 239920 SingaporeWebsite:
Home